Concurrent antiglomerular basement membrane disease and immune complex glomerulonephritis

Renal Failure

Volumn 28, Issue 1, 2006, Pages 7-14

  Cui, Zhao ^a   Zhao, Ming Hui ^a   Wang, Su Xia ^a   Liu, Gang ^a   Zou, Wan Zhong ^a   Wang, Hai Yan ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Antiglomerular basement membrane disease; Immune complexes; Pathogenesis; Prognosis

Indexed keywords

CYCLOPHOSPHAMIDE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; METHYLPREDNISOLONE;

ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CLINICAL ARTICLE; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS BASEMENT MEMBRANE; HEMODIALYSIS; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IMMUNE COMPLEX NEPHRITIS; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY GRAFT; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MESANGIUM; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; AGED; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; BIOPSY; FEMALE; GLOMERULONEPHRITIS; HUMANS; IMMUNE COMPLEX DISEASES; MALE; MIDDLE AGED;

EID: 32644461387     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220500461195     Document Type: Article

References (32)

1. Turner N, Mason PJ, Brown R, et al. Molecular cloning of human Goodpasture antigen demonstrates it to be the α3 chain of type IV collagen. J Clin Invest. 1992;89:592-601.
2. Hudson BG, Tryggvason K, Sundaramoorthy M, et al. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med. 2003;348:2543-2556.
3. Pusey CD. Anti-glomerular basement membrane disease. Kidney Int. 2003;64:1535-1550.
4. Falk RJ, Jennette C, Nachman PH. Primary glomerular disease. In: Rector FC, Brenner BM, eds. The Kidney. Vol. 2. 6th ed. Philadelphia: Saunders; 2001:1263-1349.
5. Trpkov K, Abdulkareem F, Jim K, et al. Recurrence of anti-GBM antibody disease twelve years after transplantation associated with de novo IgA nephropathy. Clin Nephrol. 1998;49:124-128.
6. Carreras L, Poveda R, Bas J, et al. Goodpasture syndrome during the course of a Schonlein-Henoch purpura. Am J Kidney Dis. 2002;39:E21.
7. Klassen J, Elwood C, Grossberg AL, et al. Evolution of membranous nephropathy into anti-glomerular basement membrane glomerulonephritis. N Engl J Med. 1974;290:1340-1344.
8. Pettersson E, Tornroth T, Miettinen A. Simultaneous anti-glomerular basement membrane and membranous glomerulonephritis: case report and literature review. Clin Immunol Immunopathol. 1984;31:171-180.
9. Thitiarchakul S, Lal SM, Luger A, et al. Goodpasture's syndrome superimposed on membranous nephropathy. A case report. Int J Artif Organs. 1995;18:763-765.
10. Kielstein JT, Helmchen U, Netzer KO, et al. Conversion of Goodpasture's syndrome into membranous glomerulonephritis. Nephrol Dial Transplant. 2001;16:2082-2085.
11. Deodhar HA, Marshall RJ, Sivathondan Y, et al. Recurrence of Goodpasture's syndrome associated with mesangiocapillary glomerulonephritis. Nephrol Dial Transplant. 1994;9:72-75.
12. Cui Z, Zhao MH. Avidity of anti-glomerular basement membrane autoantibodies was associated with disease severity. Clin Immunol. 2005;116:77-82.
13. Cui Z, Zhao MH, Xin G, et al. Characteristics and prognosis of Chinese patients with anti-glomerular basement membrane disease. Nephron Clin Pract. 2005;99:c49-55.
14. Liu N, Zhao MH, Zhang YK, et al. Anti-glomerular basement membrane autoantibodies and anti-neutrophil cytoplasmic autoantibodies in Chinese patients with rapidly progressive glomerulonephritis and their clinical implication. Clin Nephro. 1999;3:1-5.
15. Yan Y, Cui Z, Zhao MH. The distribution and clinical significance of IgG subclasses of anti-glomerular basement membrane antibodies. J Nephrol. (in press).
16. Savige JA, Dowling J, Kincaid-Smith P. Superimposed glomerular immune complexes in anti-glomerulonephritis. Am J Kidney Dis. 1989;14:145-153.
17. Kalluri R, Gunwar S, Reeders ST, et al. Goodpasture syndrome: Localization of the epitope for the autoantibodies to the carboxyl-terminal region of the alpha 3 (IV) chain of basement membrane collagen. J Biol Chem. 1991;266:24018-24024.
18. Kalluri R, Cantley LG, Kerjaschkii D, et al. Reactive oxygen species expose cryptic epitopes associated with autoimmune Goodpasture syndrome. J Biol Chem. 2000;275:20027-20032.
19. Yoshioka K, Takemura T, Murakami K, et al. In situ expression of cytokines in IgA nephritis. Kidney Int. 1993;44:825-833.
20. Lan HY, Nikolic-Paterson DJ, Mu W, et al. Local macrophage proliferation in the progression of the glomerular and tubulointerstitial injury in rat anti-GBM glomerulonephritis. Kidney Int. 1995;48:753-760.
21. Libetta C, Rampino T, Palumbo G, et al. Circulating serum lectins of patients with IgA nephropathy stimulate IL-6 release from mesangial cells. J Am Soc Nephrol. 1997;8:208-213.
22. Ikezumi Y, Hurst LA, Masaki T, et al. Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial cell proliferation.. Kidney Int. 2003;63:83-95.
23. Kamimura H, Honda K, Nitta K, et al. Glomerular expression of alpha2(IV) and alpha5(IV) chains of type IV collagen in patients with IgA nephropathy. Nephron, 2002;91:43-50.
24. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med. 2002;347:738-748.
25. Tomana M, Novak J, Julian B, et al. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest. 1999;104:73-81.
26. Kerjaschki D, Neale TJ. Molecular mechanism of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis). J Am Soc Nephrol. 1996;7:2518-2526.
27. Segelmark M, Butkowski R, Wieslander J. Antigen restriction and IgG subclasses among anti-GBM autoantibodies. Nephrol Dial Transplant. 1990;5:991-996.
28. Noel LH, Aucouturier P, Monteiro RC, et al. Glomerular and serum immunoglobulin G subclasses in membranous nephropathy and anti-glomerular basement membrane nephritis. Clin Immunol Immunopathol. 1988;46:186-194.
29. Barabas AZ, Boyd N, Cornish J, et al. Progressive passive Heymann nephritis in the rat. Lab Invest. 1982;47:400-405.
30. Unanue ER, Dixon FJ. Experimental glomerulonephritis. VI. The autologous phase of nephrotoxic serum nephritis. J Exp Med. 1965;121:715-718.
31. Dwyer DS, Bradley RJ, Urquhart CK, et al. Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients. Nature. 1983;301:611-614.
32. Levy JB, Turner AN, Rees AJ, et al. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med. 2001;134:1033-1042.